Proportion of patients achieving good, moderate, or no EULAR clinical response, where good response is defined as DAS28(ESR) ≤ 3.2 and decrease from baseline by >1.2; moderate response is defined as achievement of one of the following:

  • DAS28(ESR) ≤ 3.2 and decrease from baseline > 0.6 and ≤ 1.2,
  • DAS28(ESR) > 3.2 and ≤ 5.1 and decrease from baseline > 0.6,
  • DAS28(ESR) > 5.1 and decrease from baseline >1.2 Patients without a good or moderate response are considered to be non-responders.

Read more: http://www.clinicaltrials.gov/ct2/show/NCT01288287?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30